-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明，無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Pfizer CEO Says People Needing COVID-19 Vaccines Every Year Is The 'Most Likely Scenario'
Pfizer CEO Says People Needing COVID-19 Vaccines Every Year Is The 'Most Likely Scenario'
Pfizer Inc (NYSE:PFE) CEO Albert Bourla said that there is a likelihood that annual booster shots of the coronavirus vaccine will be needed.
What Happened: Bourla said in an interview with ABC’s “This Week” program that the COVID-19 vaccine could morph into an annual shot.
See Also: How To Buy Pfizer (PFE) Shares
“The most likely scenario for me is that, because the virus is spread all over the world, that it will continue seeing new variants that are coming out,” he said.
“Also we will have vaccines that they will last at least a year, and I think the most likely scenario is annual vaccination, but we don’t know really, we need to wait and see the data,” Bourla said.
The Pfizer CEO anticipates that "we will be able to come back to normal life” within a year.
Why It Matters: The Pfizer vaccine booster shot was approved by FDA for high-risk individuals, and for those aged 65 years and above last week.
See Also: EMA To Decide On Pfizer/BioNTech COVID-19 Booster Next Month: Reuters
Bourla’s comment that normal life could return within a year came with a caveat on emerging variants of COVID-19 and the need for continuing vaccination.
“I don’t think that this means that the variants will not continue coming, and I don’t think that this means that we should be able to live our lives without having vaccinations,” he said.
Bourla’s timeline for the end of the pandemic is similar to that proposed by Moderna Inc (NASDAQ:MRNA) CEO Stéphane Bancel.
Bancel said he expected things to return to normal a year from now when asked by the Swiss newspaper Neue Zuercher Zeitung on an estimated return to normal life, as per a Reuters report.
Pfizer CEO said in the interview, the company was going to submit data on a children’s COVID-19 vaccine in a matter of “days,” not “weeks.”
Pfizer’s vaccine is made in partnership with the German firm BioNTech SE (NASDAQ:BNTX).
Price Action: On Friday, Pfizer shares closed nearly 0.6% lower at $43.94 in regular trading. On the same day, BioNTech shares closed nearly 5.5% lower in the regular session at $333.48 and rose almost 0.6% higher to $333.50 in the after-hours trading.
Read Next: Amazon Dishes Out Cars, $100K In Rewards To Workers As It Seeks To Encourage Staff Vaccination
Pfizer Inc (NYSE:PFE) CEO Albert Bourla said that there is a likelihood that annual booster shots of the coronavirus vaccine will be needed.
輝瑞紐約證券交易所代碼：PFE)首席執行官阿爾伯特·鮑拉説有可能需要每年一次的冠狀病毒疫苗強化注射。
What Happened: Bourla said in an interview with ABC’s “This Week” program that the COVID-19 vaccine could morph into an annual shot.
發生的事情：布拉在一次採訪中説採訪隨着美國廣播公司的“本週”節目，新冠肺炎疫苗可能會變成一年一度的疫苗。
See Also: How To Buy Pfizer (PFE) Shares
“The most likely scenario for me is that, because the virus is spread all over the world, that it will continue seeing new variants that are coming out,” he said.
他説：“對我來説，最有可能的情況是，由於病毒在世界各地傳播，它將繼續看到新的變種出現。”
“Also we will have vaccines that they will last at least a year, and I think the most likely scenario is annual vaccination, but we don’t know really, we need to wait and see the data,” Bourla said.
Bourla説：“我們的疫苗將至少持續一年，我認為最有可能的情況是每年接種疫苗，但我們真的不知道，我們需要等待數據。”
The Pfizer CEO anticipates that "we will be able to come back to normal life” within a year.
這位輝瑞首席執行官預計，“我們將能夠在一年內恢復正常生活”。
Why It Matters: The Pfizer vaccine booster shot was approved by FDA for high-risk individuals, and for those aged 65 years and above last week.
重要的原因：輝瑞公司的疫苗增強劑是FDA批准對於高危個人，以及上週65歲及以上的人。
Bourla’s comment that normal life could return within a year came with a caveat on emerging variants of COVID-19 and the need for continuing vaccination.
布拉發表評論稱，正常生活可能會在一年內恢復，但同時也對新興的新冠肺炎變種提出了警告，並表示需要繼續接種疫苗。
“I don’t think that this means that the variants will not continue coming, and I don’t think that this means that we should be able to live our lives without having vaccinations,” he said.
他説：“我不認為這意味着變種病毒不會繼續出現，我也不認為這意味着我們不接種疫苗就可以生活下去。”
Bourla’s timeline for the end of the pandemic is similar to that proposed by Moderna Inc (NASDAQ:MRNA) CEO Stéphane Bancel.
Bourla提出的結束大流行的時間表與Moderna(納斯達克：信使核糖核酸)首席執行官斯特凡·班塞爾。
Bancel said he expected things to return to normal a year from now when asked by the Swiss newspaper Neue Zuercher Zeitung on an estimated return to normal life, as per a Reuters report.
據路透社報道，當瑞士報紙Neue Zuercher Zeitung問及預計恢復正常生活時，班塞爾表示，他預計一年後情況將恢復正常報告.
Pfizer CEO said in the interview, the company was going to submit data on a children’s COVID-19 vaccine in a matter of “days,” not “weeks.”
輝瑞首席執行官在採訪中表示，該公司將提交關於兒童新冠肺炎疫苗只需“幾天”，而不是“幾周”。
Pfizer’s vaccine is made in partnership with the German firm BioNTech SE (NASDAQ:BNTX).
Price Action: On Friday, Pfizer shares closed nearly 0.6% lower at $43.94 in regular trading. On the same day, BioNTech shares closed nearly 5.5% lower in the regular session at $333.48 and rose almost 0.6% higher to $333.50 in the after-hours trading.
輝瑞的疫苗是與這家德國公司合作生產的BioNTech SE(納斯達克：BNTX). 價格行動：週五，輝瑞股價在常規交易時段收低近0.6%，報43.94美元。同一天，生物科技的股價在常規交易時段收盤下跌近5.5%，至333.48美元，在盤後交易中上漲近0.6%，至333.50美元。
Read Next: Amazon Dishes Out Cars, $100K In Rewards To Workers As It Seeks To Encourage Staff Vaccination
接下來請閲讀：亞馬遜推出汽車，10萬美元獎勵工人，以鼓勵員工接種疫苗
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧